Publications by authors named "Haruki Usuda"

Claim this Profile
A
Association between Toll-like receptor 9 signaling defect and developing post-infectious irritable bowel syndrome.
Satoshi Kotani, Yoshiyuki Mishima, Kenichi Kishimoto, Akihiko Oka, Naoki Oshima, Haruki Usuda

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An increase in Fusobacterium is associated with the severity of oral mucositis after radiotherapy.
Atsushi Ue, Yukihisa Tamaki, Haruki Usuda, Unta Yamamori, Hiroshi Burioka

Sci Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-use of dentures after tooth loss is associated with elevated sodium/potassium ratios in older adults: a retrospective cohort study.
Takafumi Abe, Tsuyoshi Hamano, Haruki Usuda, Koichiro Wada, Kenta Okuyama

Front Dent Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hornerin expressed on endothelial cells via interacting with thrombomodulin modulates vascular inflammation and angiogenesis.
Takayuki Okamoto, Mai Hattori, Yukiko Katsube, Junichi Ota, Kunihiro Asanuma, Haruki Usuda

Biochim Biophys Acta Mol Cell Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A diet high in glucose and deficient in dietary fibre causes fat accumulation in the liver without weight gain.
Sonoko Karino, Haruki Usuda, Shoma Kanda, Takayuki Okamoto, Tomomi Niibayashi

Biochem Biophys Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusobacterium in oral bacterial flora relates with asymptomatic brain lesions.
Yoshie Kato, Masahiro Takamura, Koichiro Wada, Haruki Usuda, Satoshi Abe

Heliyon· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.
Michihiro Iwaki, Takaomi Kessoku, Kosuke Tanaka, Anna Ozaki, Yuki Kasai, Haruki Usuda

Hepatol Commun· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Periodontal Treatment and Usual Care for Nonalcoholic Fatty Liver Disease: A Multicenter, Randomized Controlled Trial.
Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu, Satsuki Sato, Takashi Kobayashi, Haruki Usuda

Clin Transl Gastroenterol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional study assessing the relationship between non-alcoholic fatty liver disease and periodontal disease.
Satsuki Sato, Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu, Takashi Kobayashi, Haruki Usuda

Sci Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Serum and Fecal Bile Acid Patterns With Liver Fibrosis in Biopsy-Proven Nonalcoholic Fatty Liver Disease: An Observational Study.
Yuki Kasai, Takaomi Kessoku, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Haruki Usuda

Clin Transl Gastroenterol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endotoxins and Non-Alcoholic Fatty Liver Disease.
Takaomi Kessoku, Takashi Kobayashi, Kento Imajo, Kosuke Tanaka, Atsushi Yamamoto, Haruki Usuda

Front Endocrinol (Lausanne)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective interventional trial on the effect of periodontal treatment on Fusobacterium nucleatum abundance in patients with colorectal tumours.
Tsutomu Yoshihara, Mitomu Kioi, Junichi Baba, Haruki Usuda, Takaomi Kessoku

Sci Rep· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endothelial connexin-integrin crosstalk in vascular inflammation.
Takayuki Okamoto, Eun Jeong Park, Eiji Kawamoto, Haruki Usuda, Koichiro Wada

Biochim Biophys Acta Mol Basis Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gut microbiota composition associated with hepatic fibrosis in non-obese patients with non-alcoholic fatty liver disease.
Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki, Yuki Kasai, Takashi Kobayashi, Haruki Usuda

J Gastroenterol Hepatol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Juvenile social defeat stress exposure favors in later onset of irritable bowel syndrome-like symptoms in male mice.
Kenjiro Matsumoto, Kana Takata, Daisuke Yamada, Haruki Usuda, Koichiro Wada

Sci Rep· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier.
Haruki Usuda, Takayuki Okamoto, Koichiro Wada

Int J Mol Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Leaky Gut in Nonalcoholic Fatty Liver Disease: A Novel Therapeutic Target.
Takaomi Kessoku, Takashi Kobayashi, Kosuke Tanaka, Atsushi Yamamoto, Kota Takahashi, Haruki Usuda

Int J Mol Sci· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of G9-1 in improving quality of life in patients with chronic constipation: a prospective intervention study.
Akiko Fuyuki, Takuma Higurashi, Takaomi Kessoku, Keiichi Ashikari, Tsutomu Yoshihara, Haruki Usuda

Biosci Microbiota Food Health· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Simulator-based pharmacological practice using iPad-Cloud system for medical education].
Koichiro Wada, Haruki Usuda, Tetsuya Tanaka, Takayuki Okamoto

Nihon Yakurigaku Zasshi· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lubiprostone in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled, phase 2a trial.
Takaomi Kessoku, Kento Imajo, Takashi Kobayashi, Anna Ozaki, Michihiro Iwaki, Haruki Usuda

Lancet Gastroenterol Hepatol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiota.
Noboru Misawa, Takuma Higurashi, Tomohiro Takatsu, Michihiro Iwaki, Takashi Kobayashi, Haruki Usuda

Aliment Pharmacol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale and design of a randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated phase 2a study to investigate the efficacy and safety of elobixibat in combination with cholestyramine for non-alcoholic fatty liver disease.
Takaomi Kessoku, Takashi Kobayashi, Anna Ozaki, Michihiro Iwaki, Yasushi Honda, Haruki Usuda

BMJ Open· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Human Soluble Thrombomodulin Suppresses Monocyte Adhesion by Reducing Lipopolysaccharide-Induced Endothelial Cellular Stiffening.
Takayuki Okamoto, Eiji Kawamoto, Haruki Usuda, Tetsuya Tanaka, Tetsuro Nikai

Cells· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Up-Regulated MicroRNA-27b Promotes Adipocyte Differentiation via Induction of Acyl-CoA Thioesterase 2 Expression.
Yuka Murata, Takashi Yamashiro, Takaomi Kessoku, Israt Jahan, Haruki Usuda

Biomed Res Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of PERIOdontal treatment versus usual care for Nonalcoholic liver disease: protocol of the PERION multicenter, two-arm, open-label, randomized trial.
Yohei Kamata, Takaomi Kessoku, Tomoko Shimizu, Takashi Kobayashi, Takeo Kurihashi, Haruki Usuda

Trials· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis